Trial · NCT03718338
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 22
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in visual characterization of 18F-florbetapir (Amyvid) positron emission tomography (PET) scans results after Andorgen Deprivation Therapy | 12 Months | Change From Baseline visual characterization scan results at 12 months |
| Primary | Change standardized uptake values of 18F-florbetapir (Amyvid) positron emission tomography (PET) scans results | 12 Months | Change from baseline standardized uptake values in select regions of interest at 12 months |
| Secondary | Cognitive test results: Story recall | 12 months | Change in baseline Story Recall results at 12 months |
| Secondary | Cognitive Test Results: Change in Montreal Cognitive Assessment (MOCA) | 12 Months | Change in baseline MOCA score results at 12 months |
| Secondary | Cognitive Test Results: Change in Clinical Dementia Rating Scale | 12 Months | Change in baseline Clinical Dementia Rating Scale score at 12 months |
| Secondary | Cognitive Test Results: Digit span | 12 Months | Change in baseline Digit span results at 12 months |
| Secondary | Cognitive Test Results: Letter number sequencing | 12 Months | Change in baseline Letter number sequencing results at 12 months |
| Secondary | Cognitive Test Results: Stroop Test Results | 12 Months | Change in baseline Stroop Test Results at 12 months |
| Secondary | Cognitive Test Results: Symbol Digit Modalities Test | 12 Months | Change in baseline Symbol Digit Modalities Test score at 12 months |
| Secondary | Cognitive Test Results: Visuo-Spatial Learning Test | 12 Months | Change in baseline Visuo-Spatial Learning Test results at 12 months |
| Secondary | Cognitive Test Results: Rey auditory verbal learning test (RVLT) | 12 Months | Change in baseline Rey auditory verbal learning test (RVLT) score at 12 months |
| Secondary | Inflammatory and immune markers: Change in CRP | 12 Months | Change in baseline CRP values at 12 months |
| Secondary | Inflammatory and immune markers: Change in IGFBP3 | 12 Months | Change in baseline IGFBP3 at 12 months |
| Secondary | Inflammatory and immune markers: Change in IGFBP1 | 12 Months | Change in baseline IGFBP1 at 12 months |
| Secondary | Inflammatory and immune markers: Change in IGF-1 | 12 Months | Change in baseline IGF-1 at 12 months |
| Secondary | Inflammatory and immune markers: Change in IL-6 | 12 Months | Change in baseline IL-6 at 12 months |
| Secondary | Metabolic Markers: Change in HgbA1C | 12 Months | Change in baseline HgbA1C at 12 months |
| Secondary | Metabolic Markers: Change in Estradiol | 12 Months | Change in baseline Estradiol at 12 months |
| Secondary | Metabolic Markers: Change in Follicle Stimulating Hormone (FSH) | 12 Months | Change in baseline Change in Follicle Stimulating Hormone (FSH) at 12 months |
| Secondary | Metabolic Markers: Change in Leptin | 12 Months | Change in baseline Leptin at 12 months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03718338/registered